Responses
Inflammatory arthritis
Original research
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.